Metagenomic Sequencing Market Size, Share, Growth Analysis, By End-user(Academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and clinics), By Technology(Shotgun metagenomics, 16S rRNA sequencing, whole-genome sequencing, and others), By Application(Environmental, clinical diagnostics, pharmaceuticals, and others), By Region - Industry Forecast 2024-2031

The global metagenomic sequencing market is witnessing intense competition among key players, driven by advancements in sequencing technologies and increasing demand for microbiome analysis across various industries. Companies such as Illumina Inc., Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences of California, and Qiagen N.V. dominate the market with their robust product portfolios, global presence, and strategic collaborations. These players focus on research and development activities to enhance their sequencing platforms' efficiency, accuracy, and throughput. Additionally, they actively engage in mergers, acquisitions, and partnerships to expand their market share and cater to the growing demand for metagenomic sequencing solutions globally.

Metagenomic Sequencing Market Top Player’s Company Profiles

• Illumina Inc. (United States)

• Thermo Fisher Scientific Inc. (United States)

• Pacific Biosciences of California, Inc. (United States)

• Qiagen N.V. (Netherlands)

• Oxford Nanopore Technologies Ltd. (United Kingdom)

• BGI Group (China)

• Roche Holding AG (Switzerland)

• 10x Genomics, Inc. (United States)

• Agilent Technologies, Inc. (United States)

• Bio-Rad Laboratories, Inc. (United States)

• Zymo Research Corporation (United States)

• PerkinElmer, Inc. (United States)

• Genewiz, Inc. (United States)

• Eurofins Scientific SE (Luxembourg)

• Macrogen Inc. (South Korea)

• GenapSys, Inc. (United States)

• Biomatters Ltd. (New Zealand)

• Novogene Corporation (China)

• Genomic Health, Inc. (United States)

• Genomic Vision (France)

Metagenomic Sequencing Market